Tag: ZW191
AACR 2026: Emerging Antibody-Drug Conjugates for the Treatment of Solid Tumors...
AACR 2026: Emerging Antibody-Drug Conjugates for the Treatment of Solid Tumors (Part 1)
ZW191: A Next-Generation FRα-Targeted ADC Demonstrates Promising Efficacy and Safety in...
ZW191: A Next-Generation FRα-Targeted ADC Demonstrates Promising Efficacy and Safety in Advanced Solid Tumors
AACR-NCI-EORTC: Preliminary Efficacy Data + Tolerable Safety Profile, Reinforce the...
Preliminary results from the ongoing Phase 1 study (NCT06555744) evaluating ZW191, an antibody-drug conjugate (see ADC Drugmap) targeting folate receptor-alpha (FR⍺), were presented at...
World ADC 2023 London – What to Expect
With renewed focus and commitment in creating a platform for innovative scientific insights and transformative experiences, 13th World ADC in London, held March 13...
